AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3 - Role of ApoE
Authors: Olin, KL Potter-Perigo, S Barrett, PHR Wight, TN Chait, A
Citation: Kl. Olin et al., Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3 - Role of ApoE, ART THROM V, 21(1), 2001, pp. 129-135
Oxidant stress in nephrotic syndrome: comparison of F-2-isprostanes and plasma antioxidant potential
Authors: Dogra, G Ward, N Croft, KD Mori, TA Barrett, PHR Herrmann, SE Irish, AB Watts, GF
Citation: G. Dogra et al., Oxidant stress in nephrotic syndrome: comparison of F-2-isprostanes and plasma antioxidant potential, NEPH DIAL T, 16(8), 2001, pp. 1626-1630
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
Authors: Mamo, JCL Watts, GF Barrett, PHR Smith, D James, AP Pal, S
Citation: Jcl. Mamo et al., Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?, AM J P-ENDO, 281(3), 2001, pp. E626-E632
Dietary n-3 polyunsaturated fat increases the fractional catabolic rate ofmedium-sized HDL particles in African green monkeys
Authors: Huggins, KW Colvin, PL Burleson, ER Kelley, K Sawyer, JK Barrett, PHR Rudel, LL Parks, JS
Citation: Kw. Huggins et al., Dietary n-3 polyunsaturated fat increases the fractional catabolic rate ofmedium-sized HDL particles in African green monkeys, J LIPID RES, 42(9), 2001, pp. 1457-1466
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test
Authors: Redgrave, TG Watts, GF Martins, IJ Barrett, PHR Mamo, JCL Dimmitt, SB Marais, AD
Citation: Tg. Redgrave et al., Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test, J LIPID RES, 42(5), 2001, pp. 710-715
Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits
Authors: Rashid, S Uffelman, KD Barrett, PHR Vicini, P Adeli, K Lewis, GF
Citation: S. Rashid et al., Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits, J LIPID RES, 42(2), 2001, pp. 265-271
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity
Authors: Carr, MC Hokanson, JE Zambon, A Deeb, SS Barrett, PHR Purnell, JQ Brunzell, JD
Citation: Mc. Carr et al., The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity, J CLIN END, 86(6), 2001, pp. 2831-2837
Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test
Authors: Watts, GF Barrett, PHR Marais, AD Dane-Stewart, CA Martins, IJ Dimmitt, SB Redgrave, TG
Citation: Gf. Watts et al., Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test, ATHEROSCLER, 157(2), 2001, pp. 519-523
Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia
Authors: Dane-Stewart, CA Watts, GF Mamo, JCL Dimmitt, SB Barrett, PHR Redgrave, TG
Citation: Ca. Dane-stewart et al., Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia, EUR J CL IN, 31(2), 2001, pp. 113-117
Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans
Authors: Welty, FK Lichtenstein, AH Barrett, PHR Jenner, JL Dolnikowski, GG Schaefer, EJ
Citation: Fk. Welty et al., Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans, ART THROM V, 20(7), 2000, pp. 1807-1810
Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes
Authors: Davis, TME Daly, F Walsh, JP Ilett, KF Beilby, JP Dusci, LJ Barrett, PHR
Citation: Tme. Davis et al., Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes, BR J CL PH, 49(3), 2000, pp. 223-230
Pharmacokinetics of retinyl palmitate and retinol after intramuscular retinyl palmitate administration in severe malaria
Authors: Davis, TME Binh, TQ Thu, LTA Rossi, R Danh, PT Barrett, PHR Beilby, J
Citation: Tme. Davis et al., Pharmacokinetics of retinyl palmitate and retinol after intramuscular retinyl palmitate administration in severe malaria, CLIN SCI, 99(5), 2000, pp. 433-441
Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: Pooled analysis of stable-isotope studies
Authors: Watts, GF Moroz, P Barrett, PHR
Citation: Gf. Watts et al., Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: Pooled analysis of stable-isotope studies, METABOLISM, 49(9), 2000, pp. 1204-1210
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects
Authors: Batal, R Tremblay, M Barrett, PHR Jacques, H Fredenrich, A Mamer, O Davignon, J Cohn, JS
Citation: R. Batal et al., Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects, J LIPID RES, 41(5), 2000, pp. 706-718
Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women
Authors: Wolfe, BM Barrett, PHR Laurier, L Huff, MW
Citation: Bm. Wolfe et al., Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women, J LIPID RES, 41(3), 2000, pp. 368-375
Acute effects of low density lipoprotein apheresis on metabolic parametersof apolipoprotein B
Authors: Parhofer, KG Barrett, PHR Demant, T Schwandt, P
Citation: Kg. Parhofer et al., Acute effects of low density lipoprotein apheresis on metabolic parametersof apolipoprotein B, J LIPID RES, 41(10), 2000, pp. 1596-1603
The role of the LDL receptor in apolipoprotein B secretion
Authors: Twisk, J Gillian-Daniel, DL Tebon, A Wang, L Barrett, PHR Attie, AD
Citation: J. Twisk et al., The role of the LDL receptor in apolipoprotein B secretion, J CLIN INV, 105(4), 2000, pp. 521-532
Atorvastatin improves postprandial lipoprotein metabolism in normolipidemic subjects
Authors: Parhofer, KG Barrett, PHR Schwandt, P
Citation: Kg. Parhofer et al., Atorvastatin improves postprandial lipoprotein metabolism in normolipidemic subjects, J CLIN END, 85(11), 2000, pp. 4224-4230
ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011 - An effect associated with enhanced intracellular degradation of ApoB
Authors: Wilcox, LJ Barrett, PHR Newton, RS Huff, MW
Citation: Lj. Wilcox et al., ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011 - An effect associated with enhanced intracellular degradation of ApoB, ART THROM V, 19(4), 1999, pp. 939-949
Human apolipoprotein (apo) B-48 and apoB-100 kinetics with stable isotopes
Authors: Welty, FK Lichtenstein, AH Barrett, PHR Dolnikowski, GG Schaefer, EJ
Citation: Fk. Welty et al., Human apolipoprotein (apo) B-48 and apoB-100 kinetics with stable isotopes, ART THROM V, 19(12), 1999, pp. 2966-2974
A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males
Authors: Sumner, AE Falkner, B Diffenderfer, MR Barrett, PHR Marsh, JB
Citation: Ae. Sumner et al., A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males, P SOC EXP M, 221(4), 1999, pp. 352-360
Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins
Authors: Velez-Carrasco, W Lichtenstein, AH Barrett, PHR Sun, ZY Dolnikowski, GG Welty, FK Schaefer, EJ
Citation: W. Velez-carrasco et al., Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins, J LIPID RES, 40(9), 1999, pp. 1695-1700
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoproteinB production in miniature pigs
Authors: Burnett, JR Wilcox, LJ Telford, DE Kleinstiver, SJ Barrett, PHR Newton, RS Huff, MW
Citation: Jr. Burnett et al., Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoproteinB production in miniature pigs, J LIPID RES, 40(7), 1999, pp. 1317-1327
Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
Authors: Wilcox, LJ Barrett, PHR Huff, MW
Citation: Lj. Wilcox et al., Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin, J LIPID RES, 40(6), 1999, pp. 1078-1089
Small HDL particles containing two apoA-I molecules are precursors in vivoto medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates
Authors: Colvin, PL Moriguchi, E Barrett, PHR Parks, JS Rudel, LL
Citation: Pl. Colvin et al., Small HDL particles containing two apoA-I molecules are precursors in vivoto medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates, J LIPID RES, 40(10), 1999, pp. 1782-1792
Risultati: 1-25 | 26-32